AFYA logo

AFYA LTD-CLASS A

AFYANASDAQ
πŸ† #3636 by market capUS Equity
$10.14β–Ό $0.10 (βˆ’0.93%)
Latest quote
πŸ””
Track AFYA
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 0.9%
7dβ–Ό 32.0%
14dβ–Ό 30.3%
30dβ–Ό 14.5%
ytdβ–Ό 34.2%
1yβ–Ό 29.6%
🏦Market Cap
$897M
Small Cap
πŸ“ˆRevenue Growth (YoY)
7.9%
Slowing
πŸ“ŠGross Margin
64.0%
High
πŸ’΅FCF Margin
32.9%
Strong
βš–οΈP/S Ratio
1.3x
Cheap
Otter Score
84
Strong

Trading Snapshot

Day Range
$10.03 – $10.30
52-Week Range
β€”
Volume (shares)
1,656
Avg Volume (shares)
β€”
Shares Outstanding
88.5M
Next Earnings
β€”

Fundamentals Snapshot

Annual Revenue
$3.62B
Last Q Revenue
$994M
P/E Ratio
6.4
P/S Ratio
1.3x
EPS (TTM)
β€”
Dividend Yield
β€”
Dilution (1yr)
+0.3%
AFYA logo

AFYA LTD-CLASS A

AFYA
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$3.6Bβ–² +9.7% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
64.5%β–² +2.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$1.2Bβ–² +17.5% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$1.0Bβ–Ό βˆ’0.3% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
91.0Mβ–² +0.3% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$2.0Bβ–² +$269M YoY
StockOtter Β· stockotter.space

About AFYA LTD-CLASS A

Afya Limited, operating through its subsidiaries, is a prominent medical education provider in Brazil. The company delivers a comprehensive array of educational products and services primarily focused on the medical field, encompassing medical schools, preparatory courses for medical residency, advanced graduate studies, and various other programs tailored for medical professionals at all career stages. These offerings are available across its proprietary network and are also extended to external medical institutions. Beyond traditional education, Afya also offers digital health services through a subscription-based platform, accessible via a mobile app and website. This platform is specifically designed to assist healthcare practitioners and students with clinical decision-making by providing essential tools such as medical calculators, reference charts, up-to-date content, prescription guidance, clinical scoring systems, details on medical procedures, and laboratory examination information. While strong in medicine, Afya's educational portfolio spans a broader spectrum of health sciences, including dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine. Furthermore, the company extends its academic offerings beyond healthcare to include undergraduate and postgraduate degree programs in diverse subjects like business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. The company further enhances its educational ecosystem by providing specialized postgraduate medical programs, both printed and digital educational materials, an online medical learning platform, and hands-on medical training opportunities. As of December 31, 2021, Afya maintained an extensive network of 46 undergraduate and graduate medical school campuses, which included 30 operational undergraduate units and five approved units. This infrastructure supported a total capacity of 2,731 medical school seats, with 2,481 actively operating and an additional 278 seats approved for future use. Established in 1999, Afya Limited is headquartered in Nova Lima, Brazil.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Strong
84/100
Analyst data unavailable.

Latest News & Updates

News unavailable.